Product Information
CEPHALEXIN 750 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $5.1116 per EA under NDC 67877025523. Its NADAC has been published 338 times since Jan 22, 2014.
FDA first approved this application on Dec 20, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Cephalexin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877025523
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEPHALEXINApproval Type
Generic (ANDA)
FDA Application
ANDA090836FDA Approved
12/20/2010
TE Code
AB
On Market Since
6/4/2012
Pharmacological Classes
Price Statistics
The NADAC for CEPHALEXIN 750 MG CAPSULE has been published 338 times since Jan 22, 2014, and over the history we have for it it has declined 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1116 per EA |
|---|---|
| All-time high | $6.3341 (May 15, 2024) |
| All-time low | $3.4999 (Jul 17, 2024) |
| 52-week high | $6.3030 |
| 52-week low | $4.9452 |
| Median price | $5.7332 |
| Average price | $5.6900 |
| Largest weekly change | -32.8% (May 22, 2024) |
| Weeks tracked | 338 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cephalexin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEPHALEXIN 750 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 750 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $5.1116 per EA (NDC 67877025523), effective Sep 30, 2026.
How has the price of CEPHALEXIN 750 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEPHALEXIN 750 MG CAPSULE has declined 15.0%. It has been tracked across 338 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CEPHALEXIN 750 MG CAPSULE?
Since Jan 22, 2014, the NADAC for CEPHALEXIN 750 MG CAPSULE has ranged from a low of $3.4999 (Jul 17, 2024) to a high of $6.3341 (May 15, 2024), with a median of $5.7332 per EA.
Are there cheaper alternatives to CEPHALEXIN 750 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEPHALEXIN 750 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CEPHALEXIN 750 MG CAPSULE?
CEPHALEXIN 750 MG CAPSULE (NDC 67877025523) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.